Among individuals taking the medication with standard-of-care topical corticosteroids, approximately 41% achieved clear or almost clear skin at 16 weeks. Approximately 70% of individuals with moderate-to-severe atopic dermatitis (AD) receiving lebrikizumab combined with standard-of-care topical corticosteroids (TCS) achieved at least a 75% improvement in overall disease severity in the ADhere trial at 16 weeks, Eli […]
March 17, 2022 2 min read Source/Disclosures Published by: Disclosures: Simpson reports financial relationship with AbbVie, Amgen, Arcutis, Arena Pharmaceuticals, Aslan Pharma, Boston Consulting Group, Collective Acumen, Corevita, Dermira, Eli Lilly, Evidera, Excerpta Medica, Forte Bio RX, Galderma, GlaxoSmithKline, Incyte, Janssen, Kyowa Hakko Kirin, LEO Pharmaceuticals, Medscape LLC, Merck, Novartis, Pfizer, Physicians […]